Arkolith/Insider Trading/IKNA/Form 4

Tessier Maude

Chief Business OfficerIkena Oncology, Inc. (IKNA) · full profile →Form 4 · filed Jan 20, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 18, 2022Option exercise(M)8K$4.51$37K101K
Jan 18, 2022Option exercise(M)25K$4.15$102K92K
Jan 18, 2022Option exercise(M)39K$2.94$114K68K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 18, 2022Option exercise(M)25K—$011K
Jan 18, 2022Option exercise(M)8K—$029K
Jan 18, 2022Option exercise(M)39K—$06K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-002657) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML